184 related articles for article (PubMed ID: 10049945)
1. Cytotoxic T lymphocytes to an unmutated tumor rejection antigen P1A: normal development but restrained effector function in vivo.
Sarma S; Guo Y; Guilloux Y; Lee C; Bai XF; Liu Y
J Exp Med; 1999 Mar; 189(5):811-20. PubMed ID: 10049945
[TBL] [Abstract][Full Text] [Related]
2. On the role of unmutated antigens in tumor rejection in mice with unperturbed T-cell repertoires.
Sarma S; Bai XF; Liu JQ; May KF; Zheng P; Liu Y
Cancer Res; 2003 Sep; 63(18):6051-5. PubMed ID: 14522934
[TBL] [Abstract][Full Text] [Related]
3. The shared tumor-specific antigen encoded by mouse gene P1A is a target not only for cytolytic T lymphocytes but also for tumor rejection.
Brändle D; Bilsborough J; Rülicke T; Uyttenhove C; Boon T; Van den Eynde BJ
Eur J Immunol; 1998 Dec; 28(12):4010-9. PubMed ID: 9862337
[TBL] [Abstract][Full Text] [Related]
4. Cooperative action of CD8 T lymphocytes and natural killer cells controls tumour growth under conditions of restricted T-cell receptor diversity.
Shanker A; Buferne M; Schmitt-Verhulst AM
Immunology; 2010 Jan; 129(1):41-54. PubMed ID: 20050329
[TBL] [Abstract][Full Text] [Related]
5. Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific CD8+ T cells.
May KF; Chen L; Zheng P; Liu Y
Cancer Res; 2002 Jun; 62(12):3459-65. PubMed ID: 12067989
[TBL] [Abstract][Full Text] [Related]
6. Multiple lineages of tumors express a common tumor antigen, P1A, but they are not cross-protected.
Ramarathinam L; Sarma S; Maric M; Zhao M; Yang G; Chen L; Liu Y
J Immunol; 1995 Dec; 155(11):5323-9. PubMed ID: 7594546
[TBL] [Abstract][Full Text] [Related]
7. Clonal deletion of simian virus 40 large T antigen-specific T cells in the transgenic adenocarcinoma of mouse prostate mice: an important role for clonal deletion in shaping the repertoire of T cells specific for antigens overexpressed in solid tumors.
Zheng X; Gao JX; Zhang H; Geiger TL; Liu Y; Zheng P
J Immunol; 2002 Nov; 169(9):4761-9. PubMed ID: 12391185
[TBL] [Abstract][Full Text] [Related]
8. Local costimulation reinvigorates tumor-specific cytolytic T lymphocytes for experimental therapy in mice with large tumor burdens.
Bai XF; Bender J; Liu J; Zhang H; Wang Y; Li O; Du P; Zheng P; Liu Y
J Immunol; 2001 Oct; 167(7):3936-43. PubMed ID: 11564812
[TBL] [Abstract][Full Text] [Related]
9. Different lineages of P1A-expressing cancer cells use divergent modes of immune evasion for T-cell adoptive therapy.
Bai XF; Liu JQ; Joshi PS; Wang L; Yin L; Labanowska J; Heerema N; Zheng P; Liu Y
Cancer Res; 2006 Aug; 66(16):8241-9. PubMed ID: 16912204
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
Xie Y; Bai O; Zhang H; Li W; Xiang J
Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
[TBL] [Abstract][Full Text] [Related]
11. Antigen expressed on tumor cells fails to elicit an immune response, even in the presence of increased numbers of tumor-specific cytotoxic T lymphocyte precursors.
Hermans IF; Daish A; Yang J; Ritchie DS; Ronchese F
Cancer Res; 1998 Sep; 58(17):3909-17. PubMed ID: 9731502
[TBL] [Abstract][Full Text] [Related]
12. Positive selection of gamma delta CTL by TL antigen expressed in the thymus.
Tsujimura K; Takahashi T; Morita A; Hasegawa-Nishiwaki H; Iwase S; Obata Y
J Exp Med; 1996 Dec; 184(6):2175-84. PubMed ID: 8976173
[TBL] [Abstract][Full Text] [Related]
13. The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen.
Uyttenhove C; Godfraind C; Lethé B; Amar-Costesec A; Renauld JC; Gajewski TF; Duffour MT; Warnier G; Boon T; Van den Eynde BJ
Int J Cancer; 1997 Jan; 70(3):349-56. PubMed ID: 9033639
[TBL] [Abstract][Full Text] [Related]
14. CTL response and protection against P815 tumor challenge in mice immunized with DNA expressing the tumor-specific antigen P815A.
Rosato A; Zambon A; Milan G; Ciminale V; D'Agostino DM; Macino B; Zanovello P; Collavo D
Hum Gene Ther; 1997 Aug; 8(12):1451-8. PubMed ID: 9287145
[TBL] [Abstract][Full Text] [Related]
15. B7H costimulates clonal expansion of, and cognate destruction of tumor cells by, CD8(+) T lymphocytes in vivo.
Liu X; Bai XF; Wen J; Gao JX; Liu J; Lu P; Wang Y; Zheng P; Liu Y
J Exp Med; 2001 Nov; 194(9):1339-48. PubMed ID: 11696598
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the HLA-Cw3-specific cytotoxic T lymphocyte response of HLA-B7 X human beta 2m double transgenic mice.
Barra C; Pérarnau B; Gerlinger P; Lemeur M; Gillet A; Gibier P; Lemonnier FA
J Immunol; 1989 Nov; 143(10):3117-24. PubMed ID: 2478616
[TBL] [Abstract][Full Text] [Related]
17. Localization of two cytotoxic T lymphocyte epitopes and three anchoring residues on a single nonameric peptide that binds to H-2Ld and is recognized by cytotoxic T lymphocytes against mouse tumor P815.
Van den Eynde B; Mazarguil H; Lethé B; Laval F; Gairin JE
Eur J Immunol; 1994 Nov; 24(11):2740-5. PubMed ID: 7525302
[TBL] [Abstract][Full Text] [Related]
18. On the site and mode of antigen presentation for the initiation of clonal expansion of CD8 T cells specific for a natural tumor antigen.
Bai XF; Gao JX; Liu J; Wen J; Zheng P; Liu Y
Cancer Res; 2001 Sep; 61(18):6860-7. PubMed ID: 11559562
[TBL] [Abstract][Full Text] [Related]
19. Deletion of high-avidity T cells by thymic epithelium.
Hoffmann MW; Heath WR; Ruschmeyer D; Miller JF
Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9851-5. PubMed ID: 7568231
[TBL] [Abstract][Full Text] [Related]
20. B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T cells.
Luo L; Chapoval AI; Flies DB; Zhu G; Hirano F; Wang S; Lau JS; Dong H; Tamada K; Flies AS; Liu Y; Chen L
J Immunol; 2004 Nov; 173(9):5445-50. PubMed ID: 15494491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
